Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Financial Results

Every financial results filing by a US-listed company that our alert engine sent, newest first.

4:10 PM ET 10-Q
Financial Results Sunshine Silver Mining & Refining Co SSMR

Sunshine Silver Mining & Refining Q3 2026 Results: Net Loss of $20.9M, Loss Widens

Sunshine Silver Mining & Refining Company completed its IPO in June 2026, raising $291.9 million in net proceeds, significantly strengthening its cash position to $261.4 million. The company reported a net loss of $50.9 million for the nine months ended September 30, 2026, driven primarily by increased pre-development and general administrative expenses as it scales operations.

Key figure
Net loss $20.9M
4:10 PM ET 10-Q
Financial Results TriplePoint Private Venture Credit Inc.

TriplePoint Private Venture Credit Q3 2026 Results: Net Income $20.2M, Up 577.6% YoY

TriplePoint Private Venture Credit Inc. reported a significant turnaround for the nine months ended September 30, 2026, with a net increase in net assets resulting from operations of $39.5 million compared to a $3.0 million loss in the prior year period. This improvement was primarily driven by $34.2 million in net change in unrealized gains on investments, despite a slight decrease in total investment income.

Key figure
Net income $20.2M · +577.6% YoY
4:10 PM ET 10-Q
Financial Results Northpointe Bancshares Inc NPB

Northpointe Bancshares Q3 2026 Results: Net Income $14.4M, Down 35.2% YoY

Northpointe Bancshares Inc. is an emerging growth company that operates as a non-accelerated filer. The filing highlights risks related to the mortgage banking sector, including the proposed sale of its distributed retail and consumer direct mortgage origination channels and the impact of prolonged elevated interest rates on loan demand and liquidity.

Key figure
Net income $14.4M · -35.2% YoY
4:10 PM ET 10-Q
Financial Results Virgin Galactic Holdings, Inc SPCE ▶ Call

Virgin Galactic Holdings Q3 2026 Results: Net Loss of $58.8M, Loss Narrows

Virgin Galactic reported a net loss of $58.8 million for the third quarter of 2026, an improvement from the $64.4 million loss in the prior year period. The company is focused on developing its next-generation Delta Class vehicles while managing a significant reduction in research and development expenses as it transitions through its flight fleet development phases.

Key figure
Net loss $58.8M
4:10 PM ET 10-Q
Financial Results Andersen Group Inc. ANDG ▶ Call

Andersen Group Q3 2026 Results: Net Loss of $8.98M

Andersen Group Inc. reported total assets of $758.7 million as of September 30, 2026, a significant increase from $565.1 million at year-end 2025, driven largely by higher accounts receivable and the recognition of deferred tax assets. The company maintains a dual-class stock structure and reported an accumulated deficit of $790.5 million, reflecting ongoing investments in scaling its AI-driven service offerings and business expansion.

Key figure
Net loss $8.98M
4:10 PM ET 10-Q
Financial Results Brookfield Private Equity Fund LP

Brookfield Private Equity Fund Q3 2026 Results: Turns Profitable, Net Income $26.1M

Brookfield Private Equity Fund LP is a non-accelerated filer and emerging growth company that reported various unit classes outstanding as of October 31, 2026, including 24.6 million Class B-1 units. Effective September 1, 2026, the fund ceased offering Class D units, focusing its non-Brookfield investor offerings on Class I and Class S units.

Key figure
Net income $26.1M
4:09 PM ET 8-K
Financial Results Accelevation Holdings Corp. ACCV

Accelevation Holdings Financial Results

Accelevation Holdings Corp. reported its first quarterly results as a public company, with revenue growing 66% year-over-year to $202.2 million. The company saw significant demand with bookings of $768.9 million and a backlog reaching $1.7 billion, driven by mission-critical infrastructure needs.

Term
Q3 2026

“At Accelevation, we design, manufacture, and install mission-critical infrastructure for customers who rely on our speed and certainty of delivery, and our third quarter results reflect the strength of our operating model and underlying markets.”

Michael Rubiera, Co-Founder and Chief Executive Officer

“We delivered strong growth, profitability, and cash generation in the quarter. Revenue increased more than 60%, bookings grew more than 350%, backlog rose to approximately $1.7 billion, and Adjusted EBITDA margins approached 19% following a weaker first half.”

Ken Krause, Chief Financial Officer
4:09 PM ET 8-K
Financial Results Intellicheck, Inc. IDN

Intellicheck Financial Results

Intellicheck reported its third quarter 2026 financial results, achieving its fifth consecutive quarter of profitability with net income of $0.5 million. Despite a 5% year-over-year revenue decline to $5.7 million, the company grew its cash balance to $13.2 million and maintained a strong 91% gross margin. Management highlighted expansion into new verticals like wealth management and freight logistics to combat rising synthetic identity fraud.

Term
Q3 2026

“We delivered our fifth consecutive quarter of profitability and sixth consecutive quarter of positive Adjusted EBITDA in Q3 2026, with both net income and Adjusted EBITDA up year-over-year, demonstrating the strength and durability of our business model.”

Bryan Lewis, President and Chief Executive Officer

“We remain profitable and cash from operations came in ahead of what we anticipated last quarter. Cash rose $1.3 million in the quarter to $13.2 million, our highest quarter-end level since the end of 2021, and we have no debt.”

Adam Sragovicz, Chief Financial Officer
4:09 PM ET 8-K
Financial Results NeuroPace Inc NPCE

NeuroPace Financial Results

NeuroPace reported Q3 2026 total revenue of $23.1 million, missing internal expectations due to commercial execution issues and field organization disruption. The company revised its full-year 2026 revenue guidance downward to $91-$92 million while advancing its innovation pipeline, including an FDA submission for NeuroPace Remote Care.

Term
Q3 2026

“Third-quarter revenue was below our expectations, and we have taken and are taking action to improve commercial execution and return the business to historical growth rates. The shortfall was concentrated in several of our largest accounts and reflected isolated account-level issues and changes to our field organization that created more disruption than anticipated.”

Joel Becker, President and Chief Executive Officer of NeuroPace

“Our innovation pipeline represents one of the most significant opportunities ahead for NeuroPace, combining potential indication expansion with capabilities that can make RNS therapy more accessible, efficient and personalized.”

Joel Becker, President and Chief Executive Officer of NeuroPace
4:09 PM ET 8-K
Financial Results Shimmick Corp SHIM

Shimmick Financial Results

Shimmick Corp reported Q3 2026 financial results, achieving its first quarter of positive net income since Q3 2023. Revenue for the quarter was $136 million, driven by a 28% year-over-year increase in Shimmick Projects as the company transitions away from legacy non-core work.

Term
Q3 2026

“Third quarter results show our strategy working. We returned to positive net income for the first time since the third quarter of 2023, and Shimmick Projects revenue grew 28% year over year as newer, higher-margin work replaced legacy projects. We are winning the projects we want, in the markets we want, at the risk profile we want. With strong demand in water and electrical infrastructure and a backlog that is increasingly diversified across markets, funding sources and customers, we expect to continue growing revenue and earnings from here.”

Ural Yal, Chief Executive Officer
4:09 PM ET 8-K
Financial Results Rekor Systems, Inc. REKR

Rekor Systems Financial Results

Rekor Systems reported Q3 2026 financial results, highlighting a 16% year-over-year increase in recurring revenue to $7.5 million and a significant 49% reduction in nine-month operating cash use. The company also completed a major rightsizing effort, including exiting leases in Maryland and Tel Aviv to realize over $2 million in annual savings.

4:09 PM ET 8-K
Financial Results TMC the metals Co Inc. TMC

TMC the metals Co Financial Results

TMC reported a net loss of $28.4 million for the third quarter of 2026 and provided an update on its NOAA permit application for the USA-A area. The company is working with partner Allseas on a capital-light phased approach to commercial production, targeting offshore system commissioning in Q4 2027.

Term
Q3 2026

“Our Commercial Recovery Permit application for USA-A is going through a thorough review at NOAA. Recent developments give us confidence that we could have the permit in hand by this time next year. Our focus is on being ready to mobilize for production directly after we receive it.”

Gerard Barron, Chairman & CEO of TMC
4:09 PM ET 8-K
Financial Results Obsidian Therapeutics, Inc. OBX

Obsidian Therapeutics Financial Results

Obsidian Therapeutics reported third quarter 2026 financial results, highlighting a cash position of $324.4 million following its Nasdaq debut and a $350 million financing. The company is advancing its lead TIL cell therapy candidate, amsoki-cel, with enrollment in a registration-enabling melanoma cohort expected to complete in Q1 2027.

Term
3 years

“2026 has been a transformative year so far for Obsidian. In the third quarter, we closed an oversubscribed $350 million financing, completed our transaction with Galera Therapeutics, and debuted on Nasdaq as a publicly traded company.”

Madan Jagasia, M.D., Chief Executive Officer

“The updated data we presented at SITC further strengthen our belief in the program, highlighting amsoki-cel’s consistent, favorable safety profile and encouraging clinical activity in patients with advanced melanoma, including an objective response rate of 67%, median progression-free survival of 8.3 months, and median duration of response not yet reached at median study follow-up of 14.3 months.”

Madan Jagasia, M.D., Chief Executive Officer
4:09 PM ET 8-K
Financial Results Erasca, Inc. ERAS

Erasca Financial Results

Erasca reported third quarter 2026 financial results, highlighting a strong cash position of $948 million following an upsized $632.5 million public offering in July. The company received FDA Fast Track Designation for ERAS-0015 in metastatic pancreatic adenocarcinoma and is preparing to initiate three potentially registration-enabling trials in pancreatic and lung cancers starting in 2027.

Term
Q3 2026

“The emerging clinical profile of ERAS-0015 continues to support its potential as a foundational therapy across RAS-mutant cancers, both as a monotherapy and backbone for combination regimens.”

Jonathan E. Lim, M.D., Erasca’s chairman, CEO, and co-founder

“With a strengthened balance sheet and experienced R&D leadership, we believe that we are positioned to execute our near-term milestones and advance programs addressing high unmet needs for patients with RAS-mutant cancers.”

Jonathan E. Lim, M.D., Erasca’s chairman, CEO, and co-founder
4:09 PM ET 10-Q
Financial Results Aei Income & Growth Fund 25 LLC

Aei Income & Growth Fund 25 Q3 2026 Results: Net Income $1.16M, Up 355.7% YoY

AEI Income & Growth Fund 25 LLC reported a significant increase in net income to $4,196,485 for the nine months ended September 30, 2026, primarily driven by $3,945,206 in gains from real estate sales as the fund executes its liquidation strategy. Total assets decreased from $14,389,741 to $9,194,495 during the period as the company disposed of multiple property interests and distributed proceeds to members.

Key figure
Net income $1.16M · +355.7% YoY
4:09 PM ET 10-K
Financial Results Starbucks Corp SBUX

Starbucks FY 2026 Results: Net Income $2.53B, Up 36.1% YoY

Starbucks reported that North America remains its largest segment, contributing 76% of fiscal 2026 revenues. A significant strategic shift occurred in the third quarter of fiscal 2026 with the conversion of 7,991 company-operated coffeehouses in China to a licensed joint venture model.

Key figure
Net income $2.53B · +36.1% YoY
4:09 PM ET 10-Q
Financial Results Nextnav Inc. NN

Nextnav Q3 2026 Results: Net Loss of $4.21M

NextNav Inc. reported a net loss of $4.2 million for the third quarter of 2026, a significant improvement from the $121.3 million loss in the prior year period, primarily due to a $21.4 million debt extinguishment gain and changes in warrant fair values. Total assets increased to $379.7 million as of September 30, 2026, while total liabilities decreased sharply following the conversion of 2028 Notes into common stock.

Key figure
Net loss $4.21M
4:09 PM ET 10-Q
Financial Results VivoSim Labs, INC. VIVS

VivoSim Labs Q2 2026 Results: Net Loss of $475K, Loss Narrows

VivoSim Labs reported a net loss of $1.8 million for the six months ended September 30, 2026, a significant improvement from the $5.4 million loss in the prior year period, primarily due to a $5.0 million milestone payment gain. The company transitioned its business model toward 3D human tissue model testing services following FDA regulatory shifts, while significantly increasing its outstanding share count from 2.9 million to 18.1 million during the period.

Key figure
Net loss $475K
4:09 PM ET 10-Q
Financial Results Verde Resources, Inc. VRDR

Verde Resources Q1 2026 Results: Net Loss of $868K, Loss Narrows

Verde Resources, Inc. is a non-accelerated filer and smaller reporting company focused on commercializing biochar and carbon sequestration technologies, primarily through a Master Commercialization and Collaboration Agreement with Ergon Asphalt & Emulsions. As of November 12, 2026, the company reported 1,316,068,978 shares of common stock outstanding and is in the process of scaling its licensing and distribution model.

Key figure
Net loss $868K
4:09 PM ET 10-Q
Financial Results SR Bancorp, Inc. SRBK

SR Bancorp Q1 2026 Results: Net Income $1.07M, Up 54.1% YoY

SR Bancorp reported net income of $1.07 million for the quarter ended September 30, 2026, an increase from $0.69 million in the prior year period, driven by higher net interest income. Total assets grew to $1.22 billion, while the company continued its capital management strategy through common stock repurchases and a $0.06 per share dividend.

Key figure
Net income $1.07M · +54.1% YoY
4:09 PM ET 10-Q
Financial Results Izea Worldwide, Inc. IZEA

Izea Worldwide Q3 2026 Results: Net Loss of $444K

IZEA Worldwide reported a net loss of $1.91 million for the nine months ended September 30, 2026, compared to a net income of $1.21 million in the prior year period, driven by a 26% decline in total revenue. The company maintained a strong cash position of $46.4 million despite the operational loss and continued investment in software development costs.

Key figure
Net loss $444K
4:09 PM ET 10-Q
Financial Results Macrogenics Inc MGNX

Macrogenics Q3 2026 Results: Net Loss of $20.1M

MacroGenics reported a net loss of $20.1 million for the third quarter of 2026, compared to a net income of $16.8 million in the prior year period, primarily due to a significant decrease in collaborative revenue. The company completed the sale of its CDMO operations during the year, resulting in a $95.1 million net income from discontinued operations for the nine months ended September 30, 2026.

Key figure
Net loss $20.1M
4:09 PM ET 10-Q
Financial Results Widepoint Corp WYY

Widepoint Q3 2026 Results: Net Loss of $192K, Loss Narrows

WidePoint Corp reported a significant revenue increase to $45.1 million for the quarter ended September 30, 2026, compared to $35.5 million in the prior year. Despite the revenue growth, the company recorded a net loss of $192,009 for the quarter, though this was an improvement from the $559,185 net loss reported in the same period of 2025.

Key figure
Net loss $192K
4:09 PM ET 10-Q
Financial Results Jaguar Uranium Corp. JAGU

Jaguar Uranium Q3 2026 Results: Net Loss of $1.39M, Loss Widens

Jaguar Uranium Corp. reported a net loss of $22.1 million for the nine months ended September 30, 2026, primarily driven by $17.7 million in non-cash charges related to liquidity and listing event shares following its IPO. The company significantly strengthened its balance sheet during the period, ending with $18.2 million in cash and short-term investments compared to $82,444 at the end of 2025.

Key figure
Net loss $1.39M
4:09 PM ET 10-Q
Financial Results American Integrity Insurance Group, Inc. AII ▶ Call

American Integrity Insurance Group Q3 2026 Results: Net Income $28.4M, Up 115.4% YoY

American Integrity Insurance Group, Inc. reported a significant increase in total assets to $1.62 billion as of September 30, 2026, up from $1.23 billion at year-end 2025. The company, which completed its IPO in May 2025, saw its retained earnings grow to $291.6 million while maintaining a strong cash and investment position of over $777 million.

Key figure
Net income $28.4M · +115.4% YoY
4:09 PM ET 8-K
Financial Results Liftoff Mobile, Inc. LFTO

Liftoff Mobile Financial Results

Liftoff Mobile reported Q3 2026 financial results with revenue of $238 million, up 32% year-over-year, and net income of $87 million. The company exceeded its previous guidance and issued an outlook for Q4 2026 revenue between $244 million and $249 million.

Term
Q3 2026

“Our third quarter results came in well above the high end of our previously published guidance and showed the breadth of the app economy at work. We saw strength across key app categories, as better performance for our customers drove more investment in our platform and strengthened our flywheel. We’re confident that our platform is purpose built to capture user attention and monetization for our customers.”

Jeremy Bondy, Liftoff’s Chief Executive Officer

“Our strong Q3 financial results demonstrated the earnings power of our business as we build our track record as a public company. We remain focused on delivering durable and profitable growth and strong cash generation.”

Tarek Kutrieh, Liftoff’s President and Chief Financial Officer
4:08 PM ET 8-K
Financial Results Sellas Life Sciences Group, Inc. SLS

Sellas Life Sciences Group Financial Results

SELLAS Life Sciences reported its third quarter 2026 financial results, highlighting a cash position of $134.7 million. The company expects to report topline primary endpoint results from its Phase 3 REGAL trial of GPS in AML later this month and preliminary topline data for SLS009 in first-line AML in Q4 2026.

Term
Q3 2026

“We continue to execute across both of our clinical programs as we approach several important milestones. In our ongoing Phase 3 REGAL trial of GPS, we are focused on completing the final analysis following the announcement of 80th event, and we expect to announce topline primary endpoint results this month. If successful, we believe GPS could be a transformative new immunotherapy for AML patients in second complete remission.”

Angelos Stergiou, MD, ScD h.c., President and Chief Executive Officer

“In parallel, enrollment and dosing continue in our Phase 2 trial of tambiciclib (SLS009) in newly diagnosed AML, with preliminary topline data expected in the fourth quarter. As announced earlier this month, we look forward to presenting our Phase 2 data in relapsed/refractory AML at the upcoming ASH in December. We were also encouraged by the preclinical data presented at AACR in pancreatic cancer models, including in resistance to a RAS inhibitor, and we are continuing our preparations for clinical development in that indication. With $134.7 million in cash and cash equivalents as of September 30, we are well positioned to further advance these programs.”

Angelos Stergiou, MD, ScD h.c., President and Chief Executive Officer
4:08 PM ET 8-K
Financial Results Knightscope, Inc. KSCP

Knightscope Financial Results

Knightscope reported Q3 2026 revenue of $8.7 million, a 177% increase year-over-year, driven by its new Autonomous Security Force managed service strategy. The company achieved a positive gross margin of $0.4 million compared to a gross loss in the prior year, though it recorded a net loss of $11.8 million for the quarter.

Term
Q3 2026

“We delivered our third consecutive quarter of triple-digit revenue growth, and positive gross margin in our services business. This year we redefined our go-to-market strategy around delivering security outcomes - autonomous machines, AI-driven software, and licensed security agents operating as one accountable operation under one contract.”

William Santana Li, Founder, Chairman and CEO of Knightscope

“Our priorities are clear: convert the approximately $27 million in renewals, bookings, and client awards secured since May 2026 into revenue, expand with the clients we already serve, and drive margins higher.”

William Santana Li, Founder, Chairman and CEO of Knightscope
4:08 PM ET 8-K
Financial Results Streamex Corp. STEX

Streamex Financial Results

Streamex Corp. reported Q3 2026 financial results, highlighting a net loss of $17.5 million and a total liquidity position of $36.5 million. The company saw significant growth in its tokenized gold product (GLDY), with assets under management reaching $14.0 million and external ownership doubling to 17.7%.

Term
Q3 2026

“Q1 launched GLDY, Q2 built the distribution around it, and Q3 was about scaling that distribution and adoption. Over the last ninety days, an institutional investment manager began running a gold carry strategy with GLDY as its long leg, outside ownership doubled, and the Cask Foundation began bootstrapping liquidity for its first product, USGY.”

Henry McPhie, Co-Founder and Chief Executive Officer

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.